HK1186655A1 - 含有 或其衍生物用作活性成分的抗瘧疾藥物 - Google Patents

含有 或其衍生物用作活性成分的抗瘧疾藥物

Info

Publication number
HK1186655A1
HK1186655A1 HK13113695.6A HK13113695A HK1186655A1 HK 1186655 A1 HK1186655 A1 HK 1186655A1 HK 13113695 A HK13113695 A HK 13113695A HK 1186655 A1 HK1186655 A1 HK 1186655A1
Authority
HK
Hong Kong
Prior art keywords
alaremycin
derivative
active ingredient
antimalarial drug
antimalarial
Prior art date
Application number
HK13113695.6A
Other languages
English (en)
Inventor
Wachi Masaaki
Sato Shigeharu
Tanaka Tohru
Takahashi Kiwamu
Original Assignee
Tokyo Inst Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Inst Tech filed Critical Tokyo Inst Tech
Publication of HK1186655A1 publication Critical patent/HK1186655A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK13113695.6A 2010-11-10 2013-12-10 含有 或其衍生物用作活性成分的抗瘧疾藥物 HK1186655A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010251562 2010-11-10
PCT/JP2011/006273 WO2012063487A1 (ja) 2010-11-10 2011-11-09 アラレマイシン又はその誘導体を有効成分とする抗マラリア薬

Publications (1)

Publication Number Publication Date
HK1186655A1 true HK1186655A1 (zh) 2014-03-21

Family

ID=46050652

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13113695.6A HK1186655A1 (zh) 2010-11-10 2013-12-10 含有 或其衍生物用作活性成分的抗瘧疾藥物

Country Status (5)

Country Link
US (1) US9295660B2 (zh)
EP (1) EP2638902B1 (zh)
JP (1) JP5669111B2 (zh)
HK (1) HK1186655A1 (zh)
WO (1) WO2012063487A1 (zh)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006282577A (ja) * 2005-03-31 2006-10-19 Rikogaku Shinkokai ガン光線力学治療用新規光増感剤
JP5582441B2 (ja) * 2010-05-19 2014-09-03 Ｓｂｉファーマ株式会社 ５−アミノレブリン酸又はその誘導体を有効成分とする抗マラリア薬

Also Published As

Publication number Publication date
US20130217913A1 (en) 2013-08-22
EP2638902B1 (en) 2016-02-24
JP5669111B2 (ja) 2015-02-12
US9295660B2 (en) 2016-03-29
JPWO2012063487A1 (ja) 2014-05-12
WO2012063487A1 (ja) 2012-05-18
EP2638902A1 (en) 2013-09-18
EP2638902A4 (en) 2014-04-16

Similar Documents

Publication Publication Date Title
HK1259250A1 (zh) 包含1-(β-D-吡喃葡萄糖基)-2-噻吩基-甲基苯衍生物的藥物製劑
ZA201300920B (en) Triazine derivative and pharmaceutical composition having an analgesic activity comprising the same
IL226245A0 (en) History
IL230786A (en) Heterocyclic consequence and pharmacological drug
EP2522653A4 (en) BIGUANIDE DERIVATIVE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE BIGUANIDE DERIVATIVE AS AN ACTIVE SUBSTANCE
DK2632493T3 (da) Lægemiddelindgivelsessammensætninger
GB201217593D0 (en) Delayed prolonged drug delivery
EP2560624A4 (en) THERAPEUTIC FORMULATION TO REDUCE THE SIDE EFFECTS OF MEDICATION
EP2629786A4 (en) COMPOSITIONS FOR THE ADMINISTRATION OF MEDICAMENTS
IL232035A (en) These heterocyclic compounds, these compounds as a medicine and a pharmaceutical composition containing them
HK1205462A1 (zh) 含有抗病毒活性二氫喹唑啉衍生物的藥物製劑
HK1181389A1 (zh) 包含酰胺衍生物或其可藥用鹽的藥物組合物
GB2486567B (en) Pharmaceutical formulation
EP2636666A4 (en) TRANS-2 DECENTRIC ACID DERIVATIVES AND MEDICAMENTS CONTAINING THEREOF
EP2871187A4 (en) NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT
IL223707A0 (en) N-hydroxyformamide derivative and medicament containing same
EP2476420A4 (en) PHARMACEUTICAL COMPOSITION WITH ANTIMICROBIAL AND FAST HEALING EFFECT FOR EXTERNAL ADMINISTRATION AND MANUFACTURING METHOD THEREFOR
EP2650292A4 (en) THIAZOLAMINE DERIVATIVE AND ITS PHARMACEUTICAL APPLICATIONS FOR SMALL RNA VIRAL INFECTIONS
PL2585445T3 (pl) Polimorfy aktywnego składnika farmaceutycznego
PL2474529T3 (pl) Formy krystaliczne farmaceutycznej substancji czynnej
IL226048A0 (en) A diphenyl sulfate derivative and a pharmaceutical product containing it as an active ingredient
HK1175456A1 (zh) 抗利什曼原蟲化合物以及抗利什曼原蟲藥
HK1186655A1 (zh) 含有 或其衍生物用作活性成分的抗瘧疾藥物
EP2738174A4 (en) NOVEL PYRIMIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME AS ACTIVE INGREDIENT
EP2641603A4 (en) PHARMACEUTICAL FORMULATION HAVING NEUROPROTECTIVE ACTIVITY

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20231105